4//SEC Filing
WIESEN IRVING L 4
Accession 0001654954-22-000249
CIK 0001304161other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:13 PM ET
Size
13.2 KB
Accession
0001654954-22-000249
Insider Transaction Report
Form 4
WIESEN IRVING L
Director
Transactions
- Exercise/Conversion
Common Stock
2022-01-04$0.91/sh+20,000$18,200→ 52,102 total - Tax Payment
Common Stock
2022-01-04$1.03/sh−17,670$18,200→ 34,432 total - Tax Payment
Common Stock
2022-01-04$1.03/sh−10,097$10,400→ 44,335 total - Exercise/Conversion
Common Stock
2022-01-04$0.52/sh+20,000$10,400→ 54,432 total - Exercise/Conversion
Stock Option
2022-01-04−20,000→ 0 totalExercise: $0.91Exp: 2022-01-10→ Common Stock (20,000 underlying) - Exercise/Conversion
Stock Option
2022-01-04−20,000→ 0 totalExercise: $0.52Exp: 2023-01-10→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
- [F2]Shares reported in this column have been updated to properly reflect the shares held by the reporting person following the transactions on January 4, 2021.
- [F3]The option vested in two equal installments on July 10, 2017 and July 10, 2018.
- [F4]The option vested in two equal installments on July 10, 2018 and July 10, 2019.
Documents
Issuer
Pharma-Bio Serv, Inc.
CIK 0001304161
Entity typeother
Related Parties
1- filerCIK 0001351097
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:13 PM ET
- Size
- 13.2 KB